On July 12, 2006 CMS released a guidance document titled National Coverage Determinations with Data Collection as a Condition of Coverage: Coverage with Evidence Development (CED). This document concerns the circumstances under which CMS would issue a national coverage determination (NCD) requiring, as a condition of coverage, collection of additional patient data to supplement standard claims data.
| National Coverage Determination | CED |
|---|
| 1. Cochlear Implantation | None scheduled at present |
| 2. Chemotherapy for Colorectal Cancer | A. National Cancer Institute: Clinical Trials Covered Under the Medicare Anti-Cancer Drug National Coverage Decision |
| 3. PET (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers | B. National Oncologic PET Registry |
| 4. Implantable Cardioverter Defibrillators | C. American College of Cardiology-National Cardiovascular Data Registry |
| 5. PET (FDG) for Dementia and Neurodegenerative Diseases | D. Medicare-Approved PET for Dementia Trial |
| 6. Long term oxygen treatment | E. NHLBI |
Email
Print